Preclinical products

4 preclinical products

Four preclinical GI agents that act on gastric motility and tonus via a completely new mechanism

• these compounds reduce gastric tone and relax the stomach
• these compounds are targeted at relieving symptoms in different groups of patients: a subset of severe, dyspeptic patients; patients with eating disorders; and certain patients with refractory gastro-oesophageal reflux disease (GORD)